We are live on ! Find out more
CIP

Chartwell Investment Partners Portfolio holdings

AUM $2.91B
1-Year Est. Return 40.48%
This Fund
S&P 500
This Quarter Est. Return
+11.78%
1 Year Est. Return
+40.48%
3 Year Est. Return
+57.16%
5 Year Est. Return
+148.97%
10 Year Est. Return
+397.87%
AUM
$2.89B
AUM Growth
+$38.7M
Cap. Flow
-$210M
Cap. Flow %
-7.28%
Top 10 Hldgs %
18.43%
Holding
453
New
33
Increased
146
Reduced
208
Closed
44

Top Buys

Rank Stock Value
1
CWK icon
Cushman & Wakefield Ltd
CWK
+$11.3M
2
MRVL icon
Marvell Technology
MRVL
+$9.6M
3
GTES icon
Gates Industrial Corporation Ltd.
GTES
+$9.54M
4
UNH icon
UnitedHealth
UNH
+$8.43M
5
DUK icon
Duke Energy
DUK
+$7.13M

Top Sells

Rank Stock Value
1
NVT icon
nVent Electric
NVT
+$12.9M
2
EXP icon
Eagle Materials
EXP
+$11.8M
3
HR icon
Healthcare Realty
HR
+$11.2M
4
ITGR icon
Integer Holdings
ITGR
+$10.8M
5
NEE icon
NextEra Energy
NEE
+$10.8M

Sector Composition

Rank Sector Weight
1 Technology 23.57%
2 Financials 14.29%
3 Healthcare 12.06%
4 Industrials 11.03%
5 Consumer Discretionary 9.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BANC icon
351
Banc of California
BANC
$3B
$1.12M 0.04%
73,684
+1,775
+2% +$24.7K
CCL icon
352
Carnival Corporation Ltd
CCL
$38B
$1.11M 0.04%
68,000
– –
CECO icon
353
Ceco Environmental
CECO
$4.11B
$1.1M 0.04%
47,608
+16,170
+51% +$333K
ADMA icon
354
ADMA Biologics
ADMA
$2.18B
$1.08M 0.04%
+163,938
New +$896K
MBB icon
355
iShares MBS ETF
MBB
$38.9B
$1.06M 0.04%
11,470
+2,920
+34% +$270K
ITCI
356
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$1.06M 0.04%
15,313
+3,682
+32% +$253K
WAL icon
357
Western Alliance Bancorporation
WAL
$8.78B
$1.05M 0.04%
16,395
-28,701
-64% -$1.76M
CWAN
358
DELISTED
Clearwater Analytics
CWAN
$996K 0.03%
56,307
+1,333
+2% +$24.8K
BLKB icon
359
Blackbaud
BLKB
$2.09B
$994K 0.03%
13,406
+317
+2% +$24.2K
NEO icon
360
NeoGenomics
NEO
$2.14B
$937K 0.03%
59,583
+1,425
+2% +$22K
CAH icon
361
Cardinal Health
CAH
$55.5B
$921K 0.03%
8,231
-858
-9% -$92.6K
GEHC icon
362
GE HealthCare
GEHC
$32.9B
$915K 0.03%
10,069
-9,141
-48% -$761K
BHVN icon
363
Biohaven
BHVN
$2.19B
$909K 0.03%
16,630
+4,850
+41% +$240K
PCVX icon
364
Vaxcyte
PCVX
$8.67B
$906K 0.03%
13,266
+315
+2% +$21.8K
XENE icon
365
Xenon Pharmaceuticals
XENE
$6.21B
$905K 0.03%
21,020
+500
+2% +$23K
POWI icon
366
Power Integrations
POWI
$3.46B
$888K 0.03%
12,412
+294
+2% +$22K
CRDO icon
367
Credo Technology Group
CRDO
$44.7B
$884K 0.03%
+41,716
New +$873K
HEES
368
DELISTED
H&E Equipment Services
HEES
$877K 0.03%
13,666
+323
+2% +$17.7K
ALPN
369
DELISTED
Alpine Immune Sciences Inc
ALPN
$867K 0.03%
+21,881
New +$646K
ZS icon
370
Zscaler
ZS
$28.6B
$857K 0.03%
4,450
-4,726
-52% -$1.06M
FL
371
DELISTED
Foot Locker
FL
$856K 0.03%
+30,016
New +$863K
PVH icon
372
PVH
PVH
$4.02B
$821K 0.03%
5,840
+139
+2% +$17.8K
INSM icon
373
Insmed
INSM
$29.4B
$798K 0.03%
29,416
+5,417
+23% +$152K
EXC icon
374
Exelon
EXC
$45.8B
$789K 0.03%
20,998
-22,784
-52% -$814K
FLO icon
375
Flowers Foods
FLO
$1.51B
$767K 0.03%
32,297
-34,146
-51% -$779K
13 14
15
16 17

Similar funds

CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Chartwell Investment Partners's Q1 2024 Portfolio in Review

As of Q1 2024, Chartwell Investment Partners held 453 positions worth $2.89B, up 1.4% from $2.85B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Chartwell Investment Partners withdrew a net $210M in Q1 2024, closing 44 positions and reducing 208 holdings. Its most notable exit was nVent Electric, an estimated $12.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Chartwell Investment Partners opened a new position in Cushman & Wakefield Ltd worth $11.7M.

  • Chartwell Investment Partners's largest Q1 2024 buy was Cushman & Wakefield Ltd: 1,115,950 shares worth $11.7M.
  • Chartwell Investment Partners added most to Marvell Technology in Q1 2024, an estimated $9.6M increase.
  • Chartwell Investment Partners's biggest Q1 2024 reduction was Eagle Materials, cutting an estimated $11.8M.
  • Chartwell Investment Partners fully exited nVent Electric in Q1 2024, selling an estimated $12.9M.
  • Chartwell Investment Partners's ten largest holdings make up 18% of its $2.89B portfolio in Q1 2024.
  • Chartwell Investment Partners opened 33 new positions and closed 44 in Q1 2024.
  • Chartwell Investment Partners's portfolio value rose 1.4% quarter-over-quarter to $2.89B.

Based on Chartwell Investment Partners's 13F filing for Q1 2024, filed 14 May 2024.